共 50 条
- [41] Comparative Effectiveness of Daratumumab Monotherapy Versus a Real-World Historical Control from the Czech Republic in Heavily Pretreated and Highly Refractory Multiple Myeloma PatientsBLOOD, 2016, 128 (22)Hajek, Roman论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicJelinek, Tomas论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Ostrava, Dept Haematooncol, Ostrava, Czech Republic Univ Ostrava, Fac Med, Ostrava, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicMaisnar, Vladimir论文数: 0 引用数: 0 h-index: 0机构: Fac Hosp, Dept Internal Med Hematol 4, Hradec Kralove, Czech Republic Charles Univ Hradec Kralove, Hradec Kralove, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicPour, Ludek论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic Masaryk Univ, Fac Med, Brno, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicSpicka, Ivan论文数: 0 引用数: 0 h-index: 0机构: Gen Univ Hosp, Internal Clin Clin Hematol 1, Prague, Czech Republic Charles Univ Prague, Fac Med 1, Prague, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicMinarik, Jiri论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Olomouc, Dept Hematooncol, Olomouc, Czech Republic Palacky Univ Olomouc, Fac Med & Dent, Olomouc, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicGregora, Evzen论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Kralovske Vinohrady, Dept Internal Med & Hematol, Prague, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicKessler, Petr论文数: 0 引用数: 0 h-index: 0机构: Pelhrimov Hosp, Dept Hematol & Transfus Med, Pelhrimov, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicSykora, Michal论文数: 0 引用数: 0 h-index: 0机构: Hosp Ceske Budejovice, Dept Clin Hematol, Ceske Budejovice, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicFrankova, Hana论文数: 0 引用数: 0 h-index: 0机构: Gen Hosp Liberec, Dept Hematol, Liberec, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicAdamova, Dagmar论文数: 0 引用数: 0 h-index: 0机构: Silesian Hosp Opava, Dept Clin Hematol, Opava, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicWrobel, Marek论文数: 0 引用数: 0 h-index: 0机构: Complex Oncol Ctr Novy Jicin, Novy Jicin, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicMikula, Peter论文数: 0 引用数: 0 h-index: 0机构: Gen Hosp Havirov, Dept Clin Hematol, Havirov, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech Republic论文数: 引用数: h-index:机构:Gatopoulou, Xenia论文数: 0 引用数: 0 h-index: 0机构: Janssen Hlth Econ & Market Access EMEA, Athens, Greece Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicVesela, Sarka论文数: 0 引用数: 0 h-index: 0机构: Janssen Cilag Sro, Prague, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicDiels, Joris论文数: 0 引用数: 0 h-index: 0机构: Janssen Hlth Econ & Market Access EMEA Stat & Mod, Beerse, Belgium Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicBesson, Herve论文数: 0 引用数: 0 h-index: 0机构: Janssen Hlth Econ & Market Access EMEA Stat & Mod, Beerse, Belgium Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicBrozova, Lucie论文数: 0 引用数: 0 h-index: 0机构: Masaryk Univ, Fac Med, Inst Biostat & Anal, Brno, Czech Republic Masaryk Univ, Fac Sci, Brno, Czech Republic Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech RepublicIto, Tetsuro论文数: 0 引用数: 0 h-index: 0机构: Janssen Hlth Econ & Market Access EMEA, High Wycombe, Bucks, England Univ Hosp Ostrava, Fac Med, Dept Hematooncol, Ostrava, Czech Republic
- [42] Laboratory features of tumour lysis syndrome following daratumumab monotherapy in relapsed/refractory multiple myelomaEJHAEM, 2020, 1 (01): : 312 - 314Shackleton, Louisa论文数: 0 引用数: 0 h-index: 0机构: Beaumont Hosp, Dept Haematol, Dublin, Ireland Beaumont Hosp, Dept Haematol, Dublin, IrelandFay, James论文数: 0 引用数: 0 h-index: 0机构: Beaumont Hosp, Dept Haematol, Dublin, Ireland Beaumont Hosp, Dept Haematol, Dublin, IrelandSmyth, Elizabeth论文数: 0 引用数: 0 h-index: 0机构: Beaumont Hosp, Dept Haematol, Dublin, Ireland Beaumont Hosp, Dept Haematol, Dublin, IrelandMurphy, Philip论文数: 0 引用数: 0 h-index: 0机构: Beaumont Hosp, Dept Haematol, Dublin, Ireland Beaumont Hosp, Dept Haematol, Dublin, IrelandGlavey, Siobhan论文数: 0 引用数: 0 h-index: 0机构: Beaumont Hosp, Dept Haematol, Dublin, Ireland Beaumont Hosp, Dept Haematol, Dublin, IrelandQuinn, John论文数: 0 引用数: 0 h-index: 0机构: Beaumont Hosp, Dept Haematol, Dublin, Ireland Beaumont Hosp, Dept Haematol, Dublin, Ireland
- [43] DARATUMUMAB IN MONOTHERAPY AND COMBINATION AS TREATMENT IN RELAPSED / REFRACTORY MULTIPLE MYELOMA: EXPERIENCE OF A THIRD LEVEL HOSPITALHAEMATOLOGICA, 2018, 103 : 124 - 124Auria Caballero, C.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, SpainGamarro Calvo, S.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, SpainDe Poo Rodriguez, M., V论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, SpainMartinez Fernandez, R.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, SpainSanchez Quinones, B.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, SpainDourdil Sahun, M., V论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, SpainBonafonte Arruga, E.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, SpainAlcacera Lopez, A.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, SpainPalomera Bernal, L.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Lozano Blesa, Zaragoza, Spain Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
- [44] Subcutaneous delivery of daratumumab in relapsed or refractory multiple myelomaBLOOD, 2019, 134 (08) : 668 - 677Usmani, Saad Z.论文数: 0 引用数: 0 h-index: 0机构: Atrium Hlth, Levine Canc Inst, Charlotte, NC USA Atrium Hlth, Levine Canc Inst, Charlotte, NC USANahi, Hareth论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Stockholm, Sweden Atrium Hlth, Levine Canc Inst, Charlotte, NC USAMateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Salamanca IBSAL, Salamanca, Spain Atrium Hlth, Levine Canc Inst, Charlotte, NC USAvan de Donk, Niels W. C. J.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands Atrium Hlth, Levine Canc Inst, Charlotte, NC USAChari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA Atrium Hlth, Levine Canc Inst, Charlotte, NC USAKaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA Atrium Hlth, Levine Canc Inst, Charlotte, NC USAMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Nantes, Nantes, France Atrium Hlth, Levine Canc Inst, Charlotte, NC USAOriol, Albert论文数: 0 引用数: 0 h-index: 0机构: Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain Atrium Hlth, Levine Canc Inst, Charlotte, NC USAPlesner, Torben论文数: 0 引用数: 0 h-index: 0机构: Vejle Hosp, Vejle, Denmark Univ Southern Denmark, Vejle, Denmark Atrium Hlth, Levine Canc Inst, Charlotte, NC USABenboubker, Lotfi论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Reg Univ, Hop Bretonneau, Serv Hematol & Therapie Cellulaire, Tours, France Atrium Hlth, Levine Canc Inst, Charlotte, NC USAHellemans, Peter论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Beerse, Belgium Atrium Hlth, Levine Canc Inst, Charlotte, NC USAMasterson, Tara论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Atrium Hlth, Levine Canc Inst, Charlotte, NC USAClemens, Pamela L.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Atrium Hlth, Levine Canc Inst, Charlotte, NC USALuo, Man论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Atrium Hlth, Levine Canc Inst, Charlotte, NC USALiu, Kevin论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Atrium Hlth, Levine Canc Inst, Charlotte, NC USASan-Miguel, Jesus论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, Spain Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
- [45] Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple MyelomaDrugs, 2018, 78 : 397 - 397Hannah A. Blair论文数: 0 引用数: 0 h-index: 0机构: Springer,
- [46] Real-world outcomes of daratumumab monotherapy in relapsed/refractory myelomaBRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 125 - 125论文数: 引用数: h-index:机构:Leary, H.论文数: 0 引用数: 0 h-index: 0机构: Milton Keynes Univ Hosp NHS Fdn Trust, Dept Haematol, Milton Keynes, Bucks, England Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, EnglandCollings, F.论文数: 0 引用数: 0 h-index: 0机构: Great Western Hosp NHS Fdn Trust, Dept Haematol, Swindon, Wilts, England Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, EnglandTseu, B.论文数: 0 引用数: 0 h-index: 0机构: Buckinghamshire Healthcare NHS Trust, Dept Haematol, Marlow, Bucks, England Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England论文数: 引用数: h-index:机构:Vallance, G.论文数: 0 引用数: 0 h-index: 0机构: Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, EnglandRamasamy, K.论文数: 0 引用数: 0 h-index: 0机构: Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, EnglandKothari, J.论文数: 0 引用数: 0 h-index: 0机构: Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England
- [47] The efficacy and safety of daratumumab in relapsed and refractory multiple myelomaChina Medical Abstracts(Internal Medicine), 2020, 37 (03) : 189 - 189贾亚静论文数: 0 引用数: 0 h-index: 0机构: Dept Hematol, Peking Univ People’s Hosp Dept Hematol, Peking Univ People’s Hosp
- [48] The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myelomaTHERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12Oriol, Albert论文数: 0 引用数: 0 h-index: 0机构: Carretera Escoles, Inst Josep Carreras, Carretera Canyet S-N, Barcelona 08916, Spain Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Hematol Dept, Badalona, Spain Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Trial Unit, Badalona, Spain Carretera Escoles, Inst Josep Carreras, Carretera Canyet S-N, Barcelona 08916, SpainAbril, Laura论文数: 0 引用数: 0 h-index: 0机构: Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Hematol Dept, Badalona, Spain Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Trial Unit, Badalona, Spain Carretera Escoles, Inst Josep Carreras, Carretera Canyet S-N, Barcelona 08916, SpainTorrent, Anna论文数: 0 引用数: 0 h-index: 0机构: Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Hematol Dept, Badalona, Spain Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Trial Unit, Badalona, Spain Carretera Escoles, Inst Josep Carreras, Carretera Canyet S-N, Barcelona 08916, SpainIbarra, Gladys论文数: 0 引用数: 0 h-index: 0机构: Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Hematol Dept, Badalona, Spain Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Trial Unit, Badalona, Spain Carretera Escoles, Inst Josep Carreras, Carretera Canyet S-N, Barcelona 08916, SpainRibera, Josep-Maria论文数: 0 引用数: 0 h-index: 0机构: Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Hematol Dept, Badalona, Spain Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Clin Trial Unit, Badalona, Spain Josep Carreras Leukemia Res Inst, Badalona, Spain Carretera Escoles, Inst Josep Carreras, Carretera Canyet S-N, Barcelona 08916, Spain
- [49] Real-World Safety and Efficacy of Talquetamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple MyelomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S87 - S88Shaikh, Hira论文数: 0 引用数: 0 h-index: 0机构: Univ Iowa Healthcare, Iowa City, IA USA Univ Iowa Healthcare, Iowa City, IA USALochner, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Univ Iowa Healthcare, Iowa City, IA USA Univ Iowa Healthcare, Iowa City, IA USAFriend, Reed论文数: 0 引用数: 0 h-index: 0机构: Levine Canc Inst, Charlotte, NC USA Univ Iowa Healthcare, Iowa City, IA USASnyder, Jordan论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas Hlth Syst, Kansas City, KS USA Univ Iowa Healthcare, Iowa City, IA USA论文数: 引用数: h-index:机构:Patrus, Gina论文数: 0 引用数: 0 h-index: 0机构: Allegheny Hlth Network, Philadelphia, PA USA Univ Iowa Healthcare, Iowa City, IA USADileo, Rachel论文数: 0 引用数: 0 h-index: 0机构: Allegheny Hlth Network, Philadelphia, PA USA Univ Iowa Healthcare, Iowa City, IA USAAhmed, Nausheen论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Canc Ctr, Kansas City, KS USA Univ Iowa Healthcare, Iowa City, IA USAMewawalla, Prerna论文数: 0 引用数: 0 h-index: 0机构: Allegheny Hlth Network, Philadelphia, PA USA Univ Iowa Healthcare, Iowa City, IA USAPoonsombudlert, Kittika论文数: 0 引用数: 0 h-index: 0机构: Univ Iowa Healthcare, Iowa City, IA USA Univ Iowa Healthcare, Iowa City, IA USA论文数: 引用数: h-index:机构:Wolcott, Allyson论文数: 0 引用数: 0 h-index: 0机构: Univ Iowa Healthcare, Iowa City, IA USA Univ Iowa Healthcare, Iowa City, IA USAGreen, Kimberly论文数: 0 引用数: 0 h-index: 0机构: Med Univ South Carolina, Charleston, SC USA Univ Iowa Healthcare, Iowa City, IA USASparrow, Samantha论文数: 0 引用数: 0 h-index: 0机构: Univ Iowa Healthcare, Iowa City, IA USA Univ Iowa Healthcare, Iowa City, IA USAMushtaq, Muhammad Umair论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Canc Ctr, Kansas City, KS USA Univ Iowa Healthcare, Iowa City, IA USAPaul, Barry论文数: 0 引用数: 0 h-index: 0机构: Levine Canc Inst, Charlotte, NC USA Univ Iowa Healthcare, Iowa City, IA USAAbdallah, Al-Ola论文数: 0 引用数: 0 h-index: 0机构: KUMC, Kansas City, KS USA Univ Iowa Healthcare, Iowa City, IA USAStrouse, Christopher论文数: 0 引用数: 0 h-index: 0机构: Univ Iowa Healthcare, Iowa City, IA USA Univ Iowa Healthcare, Iowa City, IA USAHashmi, Hamza论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA Univ Iowa Healthcare, Iowa City, IA USAAtrash, Shebli论文数: 0 引用数: 0 h-index: 0机构: Levine Canc Inst, Charlotte, NC USA Univ Iowa Healthcare, Iowa City, IA USA
- [50] Real-World Safety and Efficacy of Teclistamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple MyelomaBLOOD, 2023, 142Dima, Danai论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USADavis, James A.论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Med Univ South Carolina, Dept Hematol Oncol, Hollings Canc Ctr, Charleston, SC 29425 USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USAAhmed, Nausheen论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Kansas Canc Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USASannareddy, Aishwarya论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Div Hematol Malignancies & Cellular Therapy, Dept Internal Med, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USAShaikh, Hira论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Iowa Hosp & Clin, Div Hematol, Holden Comprehens Canc Ctr, Oncol & Blood Marrow Transplantat, Iowa City, IA 52242 USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USAMahmoudjafari, Zahra论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Kansas Canc Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USAKhouri, Jack论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USAKaur, Gurbakhash论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Div Hematol Malignancies & Cellular Therapy, Dept Internal Med, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USAStrouse, Christopher论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Univ Iowa Hosp & Clin, Div Hematol, Holden Comprehens Canc Ctr, Oncol & Blood Marrow Transplantat, Iowa City, IA 52242 USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USAValent, Jason论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USALarry, Anderson D., Jr.论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Div Hematol Malignancies & Cellular Therapy, Dept Internal Med, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USAAnwer, Faiz论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA论文数: 引用数: h-index:机构:Hashmi, Hamza论文数: 0 引用数: 0 h-index: 0机构: US Myeloma Innovat Res Collaborat USMIRC, Kansas City, KS USA Med Univ South Carolina, Dept Hematol Oncol, Hollings Canc Ctr, Charleston, SC 29425 USA Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA